You are here:
Home
NICE Guidance
Conditions and diseases
Mental health, behavioural and neurodevelopmental conditions
Dementia
Blarcamesine for treating mild cognitive impairment or mild dementia caused by Alzheimer’s disease [TSID12157]
Awaiting development
Reference number:
GID-TA11717
Expected publication date: TBC
Project information
Project documents
10831-Blarcamesine-for-Alzheimers-Disease-V1.0-DEC2024-NON-CONF.pdf
Back to top